About St. Luke's Meridian Medical Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Amgen
2
Janssen Research & Development, LLC
1
Pfizer
1
Clinical Trials at St. Luke's Meridian Medical Center
During the past decade, St. Luke's Meridian Medical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations
2018-03-23
2024-04-26
Recruiting
631
A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache
2019-10-07
2023-06-14
Active, not recruiting
620
Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine
2020-09-15
2024-07-21
Recruiting
576
A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.
2020-06-17
2023-11-24
Active, not recruiting
14,750
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at St. Luke's Meridian Medical Center
According to Clinical.Site data, the most researched conditions in "St. Luke's Meridian Medical Center" are
"Migraine" (1 trials), "Migraine Headache" (1 trials), "Respiratory Tract Infection" (1 trials) and "Urothelial Cancer" (1 trials). Many other conditions were trialed in "St. Luke's Meridian Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at St. Luke's Meridian Medical Center
Most popular intervention types in "St. Luke's Meridian Medical Center" are "Drug" (3 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Docetaxel" (1 trials), "Erdafitinib" (1 trials), "Erenumab" (1 trials) and "Erenumab 140mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at St. Luke's Meridian Medical Center
The vast majority of trials in "St. Luke's Meridian Medical Center" are
3 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at St. Luke's Meridian Medical Center
Currently, there are NaN active trials in "St. Luke's Meridian Medical Center".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in St. Luke's Meridian Medical Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in St. Luke's Meridian Medical Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".